New drug duo tested for Tough-to-Treat lung cancer
Disease control
Completed
This study tested whether combining two drugs, anlotinib and penpulimab, could help control small cell lung cancer in patients whose initial platinum-based chemotherapy stopped working. The goal was to see if this combination could slow cancer growth and help patients live longer…
Phase: PHASE2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated Apr 02, 2026 05:57 UTC